12.08.2018 Issue 151

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Executive Director, Health Technology Assessment (HTA) Statistics

Reporting to the Senior Vice President and Head of BARDS, the incumbent has centralized responsibility and decision making authority for all biostatistics activities in support of HTA Dossiers and submissions.

Researcher - HEOR

Executive Director, Health Technology Assessment (HTA) Statistics (U.K.)

Health Economics and Outcomes Associate Consultant

Research Data Assistant or Research Data Coordinator-PS8373

Research Associate III- Patient-Centered Research- Hammersmith

Online Instructor in Applied Health Economics

Pharmerit Lays Out Key Steps in RWE Generation Plan

Report: Environment More Friendly to OBCs

Amazon Grapples with Licensing Challenges

ICER Provides Policy Recommendations for Opioid Use Disorder Therapies

Industry Spotlight

Conferences Webinars
14th Annual Trade and Channel Strategies
    December 11-12, Philadelphia, Pennsylvania

Specialty Product Data Strategies
    December 12, Philadelphia, Pennsylvania

ESMO Immuno-Oncology Congress 2018
    December 13-16, Geneva, Switzerland

Health Economics for Non-Health-Economists
    December 13-14, Brussels, Belgium

Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA’s Expanded Access
    December 11

Intelligent Approaches to Transform Value and Access
    December 12

Managing Challenging Long-term Services and Supports Patients to Improve Care and Reduce Costs
    December 13

Identifying Medical Conditions in Administrative Claims Data: Validation and Machine Learning
    January 8

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Charting Real World Data and Evidence – Activity and Capabilities (2018)

From Patent to Patient: Analyzing Access to Innovative Cancer Drugs

Transitioning Payment Models: Fee-for-Service to Value-Based Care

How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions

Generating Consensus and Trust for Quality Measurement to Support Value-Based Care

An Evidence-Based Approach to Hiring: Leaders, Physicians, Nurses, and Front Line Staff

Special Thanks to Our Partners:
               Evidera   HealthCore  
      University of FL   Xcenda  OM1    Parexel   Jefferson
      Dymaxium   Precision Xtract    Pharmerit    eMax Health
      Sciformix   Evidence Partners    ICON    Truven